REZLIDHIA
NDC 71332-005, olutasidenib, capsule, from Rigel Pharmaceuticals, Inc..
- Product NDC
- 71332-005
- Status
- Listed
- Labeler
- Rigel Pharmaceuticals, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215814
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71332-005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OLUTASIDENIB150 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71332-005-01 | 71332000501 | 30 CAPSULE in 1 BOTTLE (71332-005-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4a0c7c8b-b95f-455d-9600-b7351e4397fe
Use it
Look up 71332-005 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71332-005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71332-005. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.